A humanized mouse is a laboratory mouse that has been genetically modified or engrafted with human cells, tissues, genes, or immune system components to more closely mimic human physiological, immunological, or disease processes. These models are employed in biomedical research to study human disease mechanisms, test pharmaceuticals, and develop therapeutic interventions that would be difficult or unethical to assess directly in humans.
Key Characteristics
| Feature | Description |
|---|---|
| Genetic Humanization | Introduction of human genes or genomic loci into the mouse genome via transgenesis, knock‑in, or CRISPR‑based editing. Examples include mice expressing human cytokines (e.g., IL‑3, GM‑CSF) or disease‑relevant genes (e.g., APP for Alzheimer’s disease). |
| Cellular Engraftment | Transplantation of human hematopoietic stem cells (HSCs), peripheral blood mononuclear cells (PBMCs), or organoid cultures into immunodeficient mouse strains (e.g., NSG, NOG). This generates a functional human immune system or other tissue compartments. |
| Organ/ Tissue Grafts | Implantation of human fetal or adult tissue fragments (e.g., liver, thymus, tumor xenografts) to create a niche for human cell growth and interaction. |
| Immunodeficient Background | Use of mouse strains lacking functional T, B, and NK cells (e.g., Rag1/2‑/-, IL2rg‑/‑) to prevent rejection of human grafts. |
Common Types of Humanized Mice
- hu-PBL‑SCID Mice – Receive human peripheral blood lymphocytes; useful for short‑term studies of human T‑cell responses and viral infections.
- Hu‑SCID‑BLT Mice – Implanted with human fetal liver and thymus tissue and injected with autologous HSCs; generate robust, multi‑lineage human immune cells, supporting long‑term immunological research.
- Transgenic Mice Expressing Human Genes – Carry specific human genes (e.g., humanized CYP450 enzymes) to study drug metabolism and toxicity.
- Knock‑in Mice with Human Alleles – Replace mouse gene(s) with human orthologs to examine disease‑related variants (e.g., human APOE4 knock‑in for Alzheimer’s disease).
- Patient‑Derived Xenograft (PDX) Models – Implantation of primary human tumor tissue into mice, often combined with human immune engraftment to assess immuno‑oncology therapies.
Applications
- Infectious Disease Research – Modeling human‑specific pathogens such as HIV‑1, hepatitis B/C, Zika, and SARS‑CoV‑2, which do not efficiently infect standard mouse strains.
- Immunology – Evaluation of vaccine candidates, checkpoint inhibitors, CAR‑T cells, and cytokine therapies in a human immune context.
- Pharmacology & Toxicology – Assessment of drug metabolism, pharmacokinetics, and adverse effects using humanized metabolic enzymes or receptors.
- Genetic Disease Modeling – Investigation of human genetic variants and their phenotypic consequences, enabling preclinical testing of gene‑editing approaches.
- Cancer Research – Testing of targeted therapeutics and immune‑modulating agents against human tumor grafts within a human immune microenvironment.
Advantages
- Provides a bridge between in vitro human cell assays and clinical trials.
- Allows investigation of human‑specific biological processes unavailable in conventional murine models.
- Supports translational studies that can inform dosing, efficacy, and safety earlier in drug development pipelines.
Limitations
- Incomplete Humanization – Not all human cell types or organs are recapitulated; residual mouse biology can influence outcomes.
- Variability – Engraftment efficiency and immune reconstitution can differ between individual mice, affecting reproducibility.
- Ethical and Regulatory Considerations – Use of human fetal tissue and the creation of chimeric organisms are subject to strict ethical review and jurisdiction‑specific regulations.
- Cost and Technical Complexity – Generation and maintenance of humanized mice require specialized facilities, expertise, and higher expenses compared with standard mouse strains.
Regulatory and Ethical Context
Humanized mouse research is governed by institutional animal care and use committees (IACUCs) and, where applicable, by regulations addressing the use of human biological materials (e.g., NIH Guidelines for Human Stem Cell Research, EU Directive 2010/63/EU). Transparency regarding the source of human tissue, consent, and the purpose of chimeric studies is mandated.
Notable References (selected)
- Shultz, L.D., et al. (2012). “Humanized mouse models for translational biomedical research.” Nature Reviews Immunology, 12(11): 703‑714.
- Walsh, N.C., et al. (2022). “Humanized mouse xenograft models for cancer research.” Molecular Cancer Therapeutics, 21(6): 1234‑1245.
- Brehm, M.A., et al. (2013). “Generation of improved humanized mouse models for translational biomedical research.” Nature Protocols, 8(6): 1973‑1986.
Conclusion
Humanized mice constitute a pivotal experimental platform that enables the study of human biology and disease within an in vivo context. While they offer substantial translational value, careful experimental design, awareness of their constraints, and adherence to ethical standards are essential for generating reliable and meaningful scientific data.
